Fertility Supplement Market- Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The fertility supplement market is segmented by Ingredient (Natural, Synthetic and Blend of Natural and Synthetic), Product (Capsules, Tablets, Soft Gels, Powders, Liquids), End-User (Women and Men), Distribution Channel (Over the Counter (OTC) and Prescribed), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The report offers the value (in USD million) for the above segments.

Market Snapshot

Fertility Supplement Market Overview
Study Period: 2019-2027
Base Year: 2021
Fastest Growing Market: Asia-Pacific
Largest Market: North America
CAGR: 7.61 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The fertility supplement market is expected to register a CAGR of 7.61% during the forecast period, 2022-2027, owing to the increasing infertility rate among women of all age groups.

The impact of the COVID-19 pandemic on the studied market was anticipated to be significant as most countries across the globe have adopted their strategies to diminish and eliminate the spread of coronavirus. Scientific societies, such as the European Society for Human Reproduction and others have provided guidelines to overcome the growing number of infections in patients who undergo In-Vito Fertilization (IVF) treatments. A research article titled “Suspension of fertility treatments during COVID-19 has mental health impacts”, published in September 2020 reported that the American Society of Reproductive Medicine and the Canadian Fertility and Andrology Society announced guidelines and recommendations to immediately suspend all in-person fertility treatments in the United States and Canada after the COVID-19 outbreak. This impacted the fertility supplements market negatively, as IVF centers are one of the major service providers for these supplements.

However, the increasing number of research and developments during the period of pandemics related to fertility supplements has contributed to the growth of the market. After the Covid-19 outbreak, Zinc became one of the household supplements. Zinc may have antiviral activity, which was thought to decrease the chances of getting infected with Covid-19 either by improving immunity which counters viral infections, or by reducing the multiplication ability of the virus. During these times in February 2021, Wayne State University School of Medicine researchers reported that people who are attempting to conceive during the pandemic may have a chance to enhance immunity against the virus and they might be able to prevent mitochondrial damage in young eggs and sperm cells.

Additionally, an article published in January 2021, titled, “Potential Role of Zinc in the COVID-19 Disease Process and its Probable Impact on Reproduction” stated that by enhancing immunity, Zinc supplements can prevent or mitigate the damage that might occur in the egg and sperm cells from the body’s immune reaction to the virus. These research and developments have increased demand for the intake of fertility supplements and have a positive impact on the studied market growth.

Moreover, the Reproduction health and Infertility FAQs reviewed in April 2021 by the Centers for Disease Control and Prevention (CDC), globally, in about 35% of couples suffering from infertility, along with a female factor, a malefactor is identified, likewise in about 8% of couples with infertility, a malefactor is the only identifiable cause. According to CDC, infertility is a widespread problem, and it is always not a women’s problem, both men and women contribute to infertility. These incidences of infertility among men and women are increasing the demand for fertility supplements and it is expected to propel in the forecast period as well.

Furthermore, the launch of fertility supplements in the market are also expected to drive the market. For instance, in April 2022, Wellbeing Nutrition launched SLOW – the time-conscious range of nutraceuticals for men and women. It Comprises of 13 supplements and each formulation has been specifically designed for a host of unique health and wellness needs such as fertility support among many others.

Where the driving factors are showing growth of the market, in contrast, the government regulations to control birth rate accompanied with violations of regulations by major companies can affect the market negatively.

Scope of the Report

As per the scope of the report, fertility supplements contain micronutrients like vitamins and minerals that the human body needs in small amounts which people take to increase their fertility. The fertility supplement market is segmented by Ingredient (Natural, Synthetic and Blend of Natural and Synthetic), Product (Capsules, Tablets, Soft Gels, and Others), Distribution Channel (Retail Pharmacy, Hospital Pharmacy and E-Pharmacy), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.

By Ingredient
Blend of Natural and Synthetic
By Product Type
Soft Gels
By Distribution Channel
Retail Pharmacy
Other Distribution Channel
North America
United States
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Middle East and Africa
South Africa
Rest of Middle East and Africa
South America
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

E-Pharmacy is Expected to Dominate the Market in the Distribution Channel Segment

Over recent years, the internet has become an acknowledged way to buy products and services. Purchasing medications online is no exception. ​

Online pharmacies are also one well-established distribution channel. They have been explored widely in the developed markets, and they are steadily being adopted in the emerging market. ​

Online drug distribution has many benefits associated with it. Disabled or homebound patients can have their medicines accessibly delivered to their homes. Shoppers relish a certain level of freedom of choice and privacy. The selection of products is massive, and medicines can be easily researched and compared.​

Moreover, considering the recent COVID-19 situation, consumers prefer to purchase medicines online, as they want to avoid going to crowded places. However, the rising number of illegal online pharmacies and counterfeit drugs also has a significant negative impact on the segment’s growth. ​

Governments and the private sector realized the importance of online channels and are implementing measures to improve visibility. Furthermore, in 2020, Amazon launched an online pharmacy in Bangalore, India, with the increasing demand faced by online channels. 

In March 2022, Online pharmacy Ro acquired Dadi, a sperm collection and testing startup, for approximately USD 100 million. With this acqusition the company is strnegthening its presence in the fertility supplements markets specially for erectile dysfucntion. 

Hence, owing to the aforementioned factors, the e-pharmacy segment of the market studied is expected to grow significantly over the forecast period.

Estimated Number of Infertility among Population, Worldwide, 2020

North America is Expected to Dominate the Fertility Supplements Market in the Forecast Period

The fertility supplement market in North America is seeing growth and is expected to grow in the forecast period owing to the increasing infertility rate among people coupled with increasing awareness among the population for overall health.

The data retrieved from the December 2021 update by Centers for Disease Control and Prevention (CDC) shows that in the United States 13.1% of women aged 15 to 49 lived with impaired fecundity, while 14.1% married women aged 15 to 49 lived with impaired fecundity, and 6% married women were found to be infertile. Also, another datasheet published by Population Reference Bureau (PRB) in August 2021 highlighted that the fertility rate for women of all age groups in high-income countries has declined since 1950 and in low-income countries also fertility rates are steadily declining for women of all age groups. As Most of the North American countries are high-income countries, it is expected to show a decline in fertility rate in women as well.

According to World Health Organization, infertility has become common due to various factors such as an increase in alcohol consumption, smoking, an increased number of obese people, increasing stress level causing hormonal imbalance and other factors. The United States Department of Health & Human Services, Men’s Health data reviewed in January 2022 shows that, in the United States, 30.9% of men aged 18 and over had five or more drinks in 1 day, 15.3% of men aged 18 or more have frequent smoking activity, 40.5% men above age of 20 are living with obesity, and 51.9% men aged 20 and over having hypertension.

While the Women’s health data reviewed on January 2022 by CDC shows that in United States, 12.7% women of age 18 or more currently smokes cigarette, 41.8% women of age 20 and over are obese, 45.2% have hypertension. As these factors are corelated with male and female infertility, most of the population in the region is attracted towards the fertility supplements as these supplements are good source of micronutrients and helps in fertility.

These increase in declining fertility rate among women and increasing number of infertile males is increasing the demand for the fertility supplements in all the distribution channels and in all the forms in the region and is expected to propel the growth of the studied market in the forecast period.

Fertility Supplement Market Analysis

Competitive Landscape

The fertility supplement market is fairly consolidated in nature and competitive rivalry is high due to the presence of a limited number of market players. The present market players compete with one another majorly by new product launches, following this moderately high bargaining power of the consumers is seen in the market. Some of the major players in the market are Fairhaven Health, Coast Science, LENUS Pharma GesmbH, Active Bio Life Science GmbH, Exeltis USA, Inc., Bionova, Fertility Nutraceuticals LLC (Ovaterra), Vitabiotics Ltd., Zenith Nutrition, Orthomol pharmazeutische Vertriebs GmbH among others.

Recent Development

  • In April 2022, Ovaterra by Fertility Nutraceuticals, a reproductive health company launched two new prenatal vitamin supplements. They are prenatal capsules formulated with the full recommended daily value of choline for pregnant and nursing women, packaged in individual servings for on-the-go.
  • In February 2022, EMD Serono, the healthcare business of Merck KGaA launched Slim Pack fertility medication packaging, reduced in size for convenience and environmental impact. It will improve portability, efficiency, and convenience.

Table of Contents


    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Infertility Rate

      2. 4.2.2 Increase in Stress Level coupled with Consumption of Alcohol and frequent smoking

      3. 4.2.3 Increasing Demand for Natural Ingredients

    3. 4.3 Market Restraints

      1. 4.3.1 Government Regulations to Control Birth Rate

      2. 4.3.2 Lack of Awareness about the Available Products

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION (Market Size by Value - USD million)

    1. 5.1 By Ingredient

      1. 5.1.1 Natural

      2. 5.1.2 Synthetic

      3. 5.1.3 Blend of Natural and Synthetic

    2. 5.2 By Product Type

      1. 5.2.1 Capsules

      2. 5.2.2 Tablets

      3. 5.2.3 Soft Gels

      4. 5.2.4 Others

    3. 5.3 By Distribution Channel

      1. 5.3.1 Retail Pharmacy

      2. 5.3.2 E-Pharmacy

      3. 5.3.3 Other Distribution Channel

    4. 5.4 Geography

      1. 5.4.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.4.2 Europe

        1. United Kingdom

        2. France

        3. Germany

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. India

        2. China

        3. Japan

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.4.4 Middle East and Africa

        1. GCC

        2. South Africa

        3. Rest of Middle East and Africa

      5. 5.4.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 Fairhaven Health

      2. 6.1.2 Coast Science

      3. 6.1.3 LENUS Pharma GesmbH

      4. 6.1.4 Active Bio Life Science GmbH

      5. 6.1.5 Exeltis USA, Inc.

      6. 6.1.6 Bionova

      7. 6.1.7 Fertility Nutraceuticals LLC (Ovaterra)

      8. 6.1.8 Vitabiotics Ltd.

      9. 6.1.9 Zenith Nutrition

      10. 6.1.10 Orthomol pharmazeutische Vertriebs GmbH

    2. *List Not Exhaustive

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Global Fertility Supplement Market market is studied from 2019 - 2027.

The Global Fertility Supplement Market is growing at a CAGR of 7.61% over the next 5 years.

Asia-Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Fairhaven Health, Coast Science, LENUS Pharma GesmbH, Exeltis USA, Inc., Vitabiotics Ltd. are the major companies operating in Global Fertility Supplement Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!